| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |